Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- AADI
- Price
- -
- Stock movement down
- -0.03 (-1.46%)
- Company name
- Aadi Bioscience Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 93.50M
- Ent value
- 79.80M
- Price/Sales
- 3.73
- Price/Book
- 1.36
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 37.40%
- 1 year return
- -6.91%
- 3 year return
- -51.24%
- 5 year return
- -56.25%
- 10 year return
- -
Last updated: 2025-09-12
DIVIDENDS
AADI does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 3.73 |
| Price to Book | 1.36 |
| EV to Sales | 3.18 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 46.29M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 30.54M |
| Net receivables | 6.54M |
| Total current assets | 77.31M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 85.70M |
| Accounts payable | 1.37M |
| Short/Current long term debt | 946.00K |
| Total current liabilities | 15.81M |
| Total liabilities | 16.83M |
| Shareholder's equity | 68.87M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| AADI | S&P500 | |
| Current price drop from All-time high | -99.86% | -7.47% |
| Highest price drop | -99.91% | -19.00% |
| Date of highest drop | 2 Jul 2024 | 8 Apr 2025 |
| Avg drop from high | -82.50% | -2.76% |
| Avg time to new high | 93 days | 5 days |
| Max time to new high | 1836 days | 89 days |
COMPANY DETAILS
Marketcap
93.50M
Marketcap category
Small-cap
Description
Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Employees
53
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner